UNH earnings analysis — 8-K, guidance, statement tables联合健康 (UNH) 财报解读 — 8-K、guidance、statement tables
English Earnings Follow-Up Analysis
This analysis is based on UnitedHealth Group’s Q2 2026 official earnings release and SEC 8-K filing:
First, core metrics beat consensus: adjusted EPS came in at $6.38, 31% above the market consensus of $4.87; total revenue hit $112.0B, 1.1% above the $110.8B consensus, a solid upside beat for a large-cap health care firm.
Second, profitability and segment performance: GAAP EPS for the quarter was $6.04, $0.34 lower than adjusted EPS, driven by $860M in favorable prior-period claim adjustments. The medical cost ratio was 86.7%, while the operating cost ratio rose 40 bps YoY to 12.7% due to targeted investments in technology and operations. UnitedHealthcare served 48.5 million members with $86.0B in revenue; Optum served over 120 million members with $65.7B in revenue, with operating margin expanding 160 bps YoY. CEO Stephen Hemsley noted that results and outlook reflect progress in simplifying operations, improving patient and provider experience, and deploying modern technology to strengthen the health care system.
Third, guidance and cash flow: The company raised full-year adjusted EPS guidance to $19.50-$20.00, and disclosed segment-level operating earnings targets, a full-year medical cost ratio range of 88.1% ±25 bps, ~$24.0B in operating cash flow, and at least $5.0B in share repurchases. Quarterly operating cash flow was $11.1B with a 41.2% debt-to-capital ratio, but full Q2 capex and free cash flow data were not provided, while Q1 2026 cash metrics were publicly available.
Finally, unresolved gaps: No earnings call transcript is available, and Q2 YoY revenue growth, segment-level YoY performance, deferred revenue and backlog details were not disclosed in the filed materials.
中文收益跟进分析
本分析基于联合健康集团2026年第二季度官方业绩发布及SEC 8-K备案文件：
首先，核心业绩均超市场共识：调整后每股收益（EPS）6.38美元，较市场预期4.87美元高出31%；总营收1120亿美元，较预期1108亿美元高出1.1%，超出幅度符合大盘健康股的典型超预期水平。
其次，盈利质量与细分表现：当季GAAP EPS为6.04美元，较调整后EPS低0.34美元，主要源于8.6亿美元的前期有利赔付调整。医疗成本率86.7%，运营成本率同比提升0.4个百分点至12.7%，对应技术、运营等领域的定向投入。联合健康保险板块服务4850万会员，营收860亿美元；Optum板块服务超1.2亿会员，营收657亿美元，运营利润率同比扩张160个基点。CEO斯蒂芬·赫姆利提及，业绩与指引反映了公司在简化运营、提升患者与医护人员体验、投入现代技术方面的进展。
第三，指引与现金流：公司上调全年调整后EPS指引至19.50-20.00美元，同时披露各细分部门运营收益、全年医疗成本率区间、约240亿美元运营现金流及至少50亿美元股票回购计划。当季运营现金流111亿美元，债务资本比率41.2%，但第二季度资本支出、自由现金流完整数据未披露，2026年第一季度相关现金数据已公开。
最后，未明确信息：暂无业绩电话会议实录，未披露第二季度营收同比增速、细分部门同比表现、递延收入及积压订单等前瞻性指标。
This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。